» Articles » PMID: 22608918

Clinical and Economic Impact of Malnutrition Per Se on the Postoperative Course of Colorectal Cancer Patients

Abstract

Background & Aims: To assess the medico-economic impact of malnutrition in patients who underwent surgery for colorectal cancer.

Methods: We performed post-hoc analyses of data from the Alves et al. prospective study. Using standard criteria of malnutrition, 2 groups were created a posteriori: Well-nourished (WN) and Mal-nourished (MN) patients. The 2 groups were statistically adjusted for age, cancer status, and scheduled surgery. Individual costs were valued using the French National Cost Study. Postoperative morbidity, mortality, hospital length-of-stay (LOS), and discharge setting were compared. We defined 3 scenarios, the most accurate estimate and its upper and lower limits, to assess the economic impact of malnutrition.

Results: 453 patients were included in the analyses. Complication and mortality rates were not significantly different between the 2 groups. MN patients had a mean LOS 3.41 days significantly longer than WN patients (p = 0.017). In MN patients, the cost of hospital stay was increased by around 3360 €, creating an annual impact of 10,159,436 € for French non-profit hospitals.

Conclusions: Malnutrition in colorectal cancer surgical patients is associated with an increased LOS resulting in significant budget impact. Further studies are needed to investigate this impact and the related cost-benefit of perioperative specialized nutritional support and implementation of the ERAS protocol in this homogeneous category of patients.

Citing Articles

The association between malnutrition risk and revised Edmonton Symptom Assessment System (ESAS-r) scores in an adult outpatient oncology population: a cross-sectional study.

McLay K, Stonewall N, Forbes L, Peters C J Patient Rep Outcomes. 2024; 8(1):71.

PMID: 38995461 PMC: 11245459. DOI: 10.1186/s41687-024-00750-8.


Nutritional Assessment Tools for Patients with Cancer: A Narrative Review.

Wang P, Soh K, Khazaai H, Ning C, Huang X, Yu J Curr Med Sci. 2024; 44(1):71-80.

PMID: 38289530 DOI: 10.1007/s11596-023-2808-4.


Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I-III colorectal cancer.

Xie H, Wei L, Liu M, Liang Y, Yuan G, Gao S BMC Cancer. 2022; 22(1):1316.

PMID: 36522702 PMC: 9756500. DOI: 10.1186/s12885-022-10405-w.


Nutritional support during the hospital stay is cost-effective for preventing adverse outcomes in patients with cancer.

Schuetz P, Sulo S, Walzer S, Krenberger S, Brunton C Front Oncol. 2022; 12:916073.

PMID: 36016618 PMC: 9396738. DOI: 10.3389/fonc.2022.916073.


Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer.

Greathouse K, Wyatt M, Johnson A, Toy E, Khan J, Dunn K Neoplasia. 2022; 29:100800.

PMID: 35500546 PMC: 9065883. DOI: 10.1016/j.neo.2022.100800.